Participant Tracking and Tracing in the PLCO and NLST/LSS Trials
There are no hypotheses to be tested. This is a descriptive manuscript. 1. Describe tracking and tracing methods: Indicate which methods were used at which centers. Describe the degree of success of each method. Discuss why some methods work and others did not. 2. Discuss lessons learned about tracking and tracing in a large clinical trial: Screening centers will discuss what they learned with the hope that others in the clinical trials community will benefit from this knowledge.
Amy Garrett (Georgetown)
Deb Engelhard (University of Minnesota)
Darlene Higgins (UAB)
Betsy Gahagan (University of Pittsburgh)
Gavin Watt (University of Minnesota)
Robin Haverman (Washington University)
Jill Cordes (University of Minnesota)
Jeff Childs (University of Utah)
Julie Varner (University of Utah)
Karen Browski (Henry Ford Hospital)
Karen Lappe (Marshfield)
Lisa Gren (University of Utah)
Lois Lamerato (Henry Ford Hospital)
Heidi Lowery (Washington University)
Colleen McGuire (Georgetown)
Mindy Geisser (University of Minnesota)
Deb Multerer (Marshfield)
Jeff Schragin (University of Pittsburgh)
Shannon Pretzel (Colorado)
Sheryl Ogden (Colorado)
Dee Sullivan
Vicki Jenkings (PHRI)
Bonita Wohler (St. Luke's)
-
Tracking and tracing of participants in two large cancer screening trials.
Marcus PM, Childs J, Gahagan B, Gren LH
Contemp Clin Trials. 2012 Jul; Volume 33 (Issue 4): Pages 601-5 PUBMED